I agree that this site is using cookies. You can find further informations here.
X
D'Offizi, G.
128  results:
Search for persons X
?
1

Bulevirtide monotherapy prevents liver decompensation and r..:

Degasperi, E. ; De Silvestri, A. ; Anolli, M.P....
Digestive and Liver Disease.  56 (2024)  - p. S31-S32 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Virological and clinical outcomes of patients with HDV-rela..:

Anolli, M.P. ; Degasperi, E. ; Jachs, M....
Digestive and Liver Disease.  56 (2024)  - p. S7-S8 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Baseline predictors of virological and biochemical response..:

Degasperi, E. ; Anolli, M.P. ; D'Offizi, G....
Digestive and Liver Disease.  56 (2024)  - p. S32-S33 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Extension of Bulevirtide monotherapy to 72 weeks in HDV pat..:

Anolli, M.P. ; Degasperi, E. ; D'Offizi, G....
Digestive and Liver Disease.  55 (2023)  - p. S7 , 2023
Link: https://doi.org/10.1016/..
 
?
5

The Fibrosis-4 index is associated with Intensive Care Unit..:

Biliotti, E. ; Piselli, P. ; Visco Comandini, U....
Digestive and Liver Disease.  53 (2021)  - p. S21-S22 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Overall survival and incidence of liver-related events in a..:

Masetti, C. ; Marignani, M. ; Lionetti, R....
Digestive and Liver Disease.  51 (2019)  - p. e57 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Lack of reduction of serum alphafetoprotein during treatmen..:

Masetti, C. ; Lionetti, R. ; Lupo, M....
Digestive and Liver Disease.  50 (2018)  1 - p. 4 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Lack of reduction of serum alphafetoprotein during treatmen..:

Masetti, C. ; Lionetti, R. ; Lupo, M....
Journal of Hepatology.  68 (2018)  - p. S533 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show..:

Cimini, E. ; Bordoni, V. ; Sacchi, A....
Virus Research.  243 (2018)  - p. 31-35 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Lower proportion of sustained virologic response and higher..:

Mastrorosa, I. ; Comandini, U.V. ; Ammassari, A....
Journal of Hepatology.  66 (2017)  1 - p. S510 , 2017
Link: https://doi.org/10.1016/..
 
?
11

P.09.4: Effectiveness of HCV Antiviral Treatment in Patient..:

Ponziani, F.R. ; Siciliano, M. ; Lionetti, R....
Digestive and Liver Disease.  49 (2017)  - p. e188-e189 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Effectiveness of HCV antiviral treatment in patients with c..:

Ponziani, F.R. ; Siciliano, M. ; Lionetti, R....
Digestive and Liver Disease.  49 (2017)  1 - p. e24-e25 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Improved virological outcomes and excellent safety profile ..:

Lionetti, R. ; Lenci, I. ; Siciliano, M....
Journal of Hepatology.  66 (2017)  1 - p. S731 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Virological and clinical significance of detectable HCV-RNA..:

Comandini, U.V. ; Lapa, D. ; Lionetti, R....
Journal of Hepatology.  66 (2017)  1 - p. S744 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-res..:

Taibi, C. ; Tempestilli, M. ; D'Avolio, A....
Journal of Clinical Pharmacy and Therapeutics.  42 (2017)  5 - p. 621-623 , 2017
Link: https://doi.org/10.1111/..
 
1-15